Colorado hospital system says it won't perform transplants on unvaccinated patients

The Colorado hospital system UCHealth said in order to protect patients, it is requiring COVID-19 vaccination for transplant recipients and donors "in almost all situations."
"For transplant patients who contract COVID-19, the mortality rate ranges from about 20 percent to more than 30 percent," UCHealth told CBS Denver in a statement. "This shows the extreme risk that COVID-19 poses to transplant recipients after their surgeries." In Colorado, 62.05 percent of residents are vaccinated.
Leilani Lutali has stage 5 renal failure, and met her kidney donor, Jaimee Fougner, at Bible study. Lutali and Fougner are not vaccinated, with Fougner saying she doesn't want to get the vaccine for religious reasons. In September, UCHealth sent them both a letter about the vaccination policy, saying they had 30 days to get their first dose. If they refuse, Lutali and Fougner will be removed from the transplant list.
Subscribe to The Week
Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.

Sign up for The Week's Free Newsletters
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
"I said I'll sign a medical waiver," Lutali told CBS Denver. "I have to sign a waiver anyway for the transplant itself, releasing them from anything that could possibly go wrong. It's surgery, it's invasive. I sign a waiver for my life. I'm not sure why I can't sign a waiver for the COVID shot." So far, Lutali and Fougner haven't been able to find any other hospital in Colorado that will perform the transplant while they are unvaccinated.
UCHealth said shots are nothing new for transplant recipients — most receive vaccinations, like MMR and hepatitis B, as a way to increase the likelihood that the transplant will be successful.
Sign up for Today's Best Articles in your inbox
A free daily email with the biggest news stories of the day – and the best features from TheWeek.com
Catherine Garcia has worked as a senior writer at The Week since 2014. Her writing and reporting have appeared in Entertainment Weekly, The New York Times, Wirecutter, NBC News and "The Book of Jezebel," among others. She's a graduate of the University of Redlands and the Columbia University Graduate School of Journalism.
-
There is a 'third state' between life and death
Under the radar Cells can develop new abilities after their source organism dies
By Devika Rao, The Week US Published
-
Is it worth getting an interest-only mortgage?
The Explainer Your monthly payments may be cheaper but the full mortgage amount will need to be paid back eventually
By Marc Shoffman, The Week UK Published
-
Crossword: March 6, 2025
The Week's daily crossword
By The Week Staff Published
-
Texas outbreak brings 1st US measles death since 2015
Speed read The outbreak is concentrated in a 'close-knit, undervaccinated' Mennonite community in rural Gaines County
By Rafi Schwartz, The Week US Published
-
Mystery illness spreading in Congo rapidly kills dozens
Speed Read The World Health Organization said 53 people have died in an outbreak that originated in a village where three children ate a bat carcass
By Peter Weber, The Week US Published
-
Ozempic can curb alcohol cravings, study finds
Speed read Weight loss drugs like Ozempic and Wegovy may also be helpful in limiting alcohol consumption
By Peter Weber, The Week US Published
-
New form of H5N1 bird flu found in US dairy cows
Speed Read This new form of bird flu is different from the version that spread through herds in the last year
By Peter Weber, The Week US Published
-
Microplastics accumulating in human brains, study finds
Speed Read The amount of tiny plastic particles found in human brains increased dramatically from 2016 to 2024
By Peter Weber, The Week US Published
-
FDA approves painkiller said to thwart addiction
Speed Read Suzetrigine, being sold as Journavx, is the first new pharmaceutical pain treatment approved by the FDA in 20 years
By Rafi Schwartz, The Week US Published
-
Study finds possible alternative abortion pill
Speed Read An emergency contraception (morning-after) pill called Ella could be an alternative to mifepristone for abortions
By Peter Weber, The Week US Published
-
How close are we to a norovirus vaccine?
Today's Big Question A new Moderna trial raises hopes of vanquishing a stomach bug that sickens millions a year
By David Faris Published